These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2606679)

  • 21. Pharmacokinetic characterization of a natural product-inspired novel MEK1 inhibitor E6201 in preclinical species.
    Kumar V; Schuck EL; Pelletier RD; Farah N; Condon KB; Ye M; Rowbottom C; King BM; Zhang ZY; Saxton PL; Wong YN
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):229-37. PubMed ID: 21698359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The allometric approach for interspecies scaling of pharmacokinetic parameters.
    Ritschel WA; Vachharajani NN; Johnson RD; Hussain AS
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Oct; 103(2):249-53. PubMed ID: 1360380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An interspecies extrapolation of the pharmacokinetics of telavancin, a rapidly bactericidal, concentration-dependent antibiotic.
    Shaw JP; Jaw-Tsai S
    Xenobiotica; 2011 Jan; 41(1):82-9. PubMed ID: 20946087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allometric relationships between the pharmacokinetics of propofol in rats, children and adults.
    Knibbe CA; Zuideveld KP; Aarts LP; Kuks PF; Danhof M
    Br J Clin Pharmacol; 2005 Jun; 59(6):705-11. PubMed ID: 15948935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interspecies pharmacokinetic scaling of a new carbapenem, DA-1131, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
    Kim SH; Kim WB; Lee MG
    Biopharm Drug Dispos; 1998 May; 19(4):231-5. PubMed ID: 9604122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of clearance, volume of distribution and half-life by allometric scaling and by use of plasma concentrations predicted from pharmacokinetic constants: a comparative study.
    Mahmood I
    J Pharm Pharmacol; 1999 Aug; 51(8):905-10. PubMed ID: 10504028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mixed effect modeling of sumatriptan pharmacokinetics during drug development. I: Interspecies allometric scaling.
    Cosson VF; Fuseau E; Efthymiopoulos C; Bye A
    J Pharmacokinet Biopharm; 1997 Apr; 25(2):149-67. PubMed ID: 9408857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Across-species meta-analysis of dexamethasone pharmacokinetics utilizing allometric and scaling modeling approaches.
    Song D; Jusko WJ
    Biopharm Drug Dispos; 2021 May; 42(5):191-203. PubMed ID: 33638217
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of human pharmacokinetics of activated recombinant factor VII and B-domain truncated factor VIII from animal population pharmacokinetic models of haemophilia.
    Larsen MS; Juul RV; Groth AV; Simonsson USH; Kristensen AT; Knudsen T; Agersø H; Kreilgaard M
    Eur J Pharm Sci; 2018 Mar; 115():196-203. PubMed ID: 29369801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance.
    Mahmood I; Balian JD
    J Pharm Sci; 1996 Apr; 85(4):411-4. PubMed ID: 8901079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prediction of Clearance, Volume of distribution, and Half-life of Drugs in Extremely Low to Low Birth Weight Neonates: An Allometric Approach.
    Mahmood I
    Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):601-610. PubMed ID: 27562171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetic principles behind scaling from preclinical results to phase I protocols.
    Mahmood I; Balian JD
    Clin Pharmacokinet; 1999 Jan; 36(1):1-11. PubMed ID: 9989339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allometric scaling of marbofloxacin pharmacokinetics: a retrospective analysis.
    Yohannes S; Hossain MA; Kim JY; Lee SJ; Kwak DM; Suh JW; Park SC
    Pol J Vet Sci; 2014; 17(1):99-103. PubMed ID: 24724476
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interspecies extrapolation of physiological pharmacokinetic parameter distributions.
    Watanabe KH; Bois FY
    Risk Anal; 1996 Dec; 16(6):741-54. PubMed ID: 8972106
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interspecies pharmacokinetic comparisons and allometric scaling of napsagatran, a low molecular weight thrombin inhibitor.
    Lavé T; Portmann R; Schenker G; Gianni A; Guenzi A; Girometta MA; Schmitt M
    J Pharm Pharmacol; 1999 Jan; 51(1):85-91. PubMed ID: 10197423
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interspecies differences and scaling for the pharmacokinetics of xanthine derivatives.
    Tsunekawa Y; Hasegawa T; Nadai M; Takagi K; Nabeshima T
    J Pharm Pharmacol; 1992 Jul; 44(7):594-9. PubMed ID: 1357141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
    Bae SK; Lee SJ; Kim YG; Kim SH; Kim JW; Kim T; Lee MG
    Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Approaches for predicting human pharmacokinetics using interspecies pharmacokinetic scaling.
    Kang HE; Lee MG
    Arch Pharm Res; 2011 Nov; 34(11):1779-88. PubMed ID: 22139680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
    Shim HJ; Kim YC; Lee JH; Kwon JW; Kim WB; Kim YG; Kim SH; Lee MG
    Biopharm Drug Dispos; 2005 Oct; 26(7):269-77. PubMed ID: 15991256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interspecies allometric scaling: prediction of clearance in large animal species: part II: mathematical considerations.
    Martinez M; Mahmood I; Hunter RP
    J Vet Pharmacol Ther; 2006 Oct; 29(5):425-32. PubMed ID: 16958788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.